Results 21 to 30 of about 1,141 (148)

Clinical update on cutaneous and subcutaneous sarcomas

open access: yesJournal of Cosmetic Dermatology, Volume 22, Issue 2, Page 402-409, February 2023., 2023
Abstract Background Cutaneous sarcomas are uncommon cancers that can have a wide range of clinical symptoms and lead to considerable cutaneous as well as systemic morbidity. Aim The objective of this review article is to discuss epidemiology, clinical features, diagnosis, and therapy of different types of cutaneous sarcomas.
Jyoti Kumari   +5 more
wiley   +1 more source

A Rare Case of Ruptured Tailgut Cyst Leading to Carcinomatosis

open access: yesCase Reports in Pathology, Volume 2023, Issue 1, 2023., 2023
Tailgut cysts are congenital cysts arising in the retrorectal space. They are thought to be benign with variable malignancy risks. We report a case with previous surgical intervention decades prior that had undergone a tailgut cyst excision with surgical complications leading to carcinomatosis.
Samir Atiya   +4 more
wiley   +1 more source

A Pulmonary Zebra: Adult Primary Pulmonary Synovial Sarcoma

open access: yesCase Reports in Oncological Medicine, Volume 2022, Issue 1, 2022., 2022
Primary pulmonary synovial sarcoma (PPSS) is an extremely rare tumor, with approximately 50 cases being reported in the English literature (Golota et al., 2018). Difficulties are often encountered in the diagnosis of PPSS as it can be confused with other spindle or round cell tumors, such as fibrosarcoma, hemangiopericytoma, mesothelioma, sarcomatoid ...
Sheffield Sandra   +3 more
wiley   +1 more source

Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1

open access: yesMolecular Genetics &Genomic Medicine, Volume 9, Issue 12, December 2021., 2021
This is the first genetic study of NF1 in North Africa which Investigating NF type I in Egyptian Population, through evaluating NF1 patients frequenting the Genodermatoses Clinic over the past three years for better understanding the disease and its effect on patients’ clinical manifestations.
Nahla N. Abdel‐Aziz   +6 more
wiley   +1 more source

Malignant peripheral nerve sheath tumours and neurofibromatosis 1: A case series and recommendations for care

open access: yesSouth African Journal of Oncology, 2018
Background: The incidence of malignant peripheral nerve sheath tumours (MPNST) in patients with neurofibromatosis 1 (NF1) is significantly higher than that of the general population. NF1-associated MPNST occur at a younger age and carry a worse prognosis
Henriette Burger   +5 more
doaj   +1 more source

Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis

open access: yesWorld Journal of Surgical Oncology, 2004
Background Type 1 neurofibromatosis (NF-1) is an autosomal dominant disorder with variable penetrance; approximately 50% of cases present as new mutations Case report We report a case of a 56 year-old man with Von Recklinghausen's disease, carcinoma of ...
Fisher Cyril   +4 more
doaj   +1 more source

Multiple Primary Cardiac Malignant Peripheral Nerve Sheath Tumors in the Left Atrium: Case Report

open access: yesJournal of Chest Surgery, 2021
Malignant peripheral nerve sheath tumors are rare sarcomas of the heart. Herein, we report the case of a 24-year-old man who complained of dyspnea, cough, and upper left back pain.
Junfei Li   +3 more
doaj   +1 more source

Interdigital neuroma in a patient with macrodactyly of the hallux

open access: yesJournal of the Foot & Ankle, 2020
A patient with macrodactyly of the hallux, returned 2 years after amputation of the distal phalanx, complaining of pain and swelling in the plantar foot. The Tinel, Moulder, and Gauthier signs were all present.
Henrique Santos Barbosa da Silva   +5 more
doaj   +1 more source

Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1 [PDF]

open access: yesYeungnam University Journal of Medicine, 2019
Malignant peripheral nerve sheath tumor (MPNST) is rare, accounting for 5–10% of all soft tissue sarcomas. MPNST is characteristically aggressive and has a poor prognosis. Fifty percent of patients with MPNST have neurofibromatosis type 1 (NF1).
Chang Yeon Jung   +3 more
doaj   +1 more source

A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy

open access: yesPharmaceutics, 2020
Neurofibromatosis type 1 (NF1) is an inherited neurological disorder. Approximately 5–13% of NF1 patients may develop a malignant peripheral nerve sheath tumor (MPNST), which is a neurofibrosarcoma transformed from the plexiform neurofibroma or ...
Chin-Tin Chen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy